Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
567 News Items found
Media Advisory
First Comprehensive Analysis Of Gene Mutations In Ovarian Cancer Brings Patients One Step Closer To Personalized Medicine

According to a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan- Kettering Cancer Center and other centers within The Cancer Genome Atlas (TCGA) project identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well.
Groundbreaking Advances In The Treatment Of Advanced Melanoma Led By Physician-Researchers At Memorial Sloan Kettering Cancer Center

In an extraordinary demonstration of excellence, positive results from two separate studies of new therapies for the treatment of advanced melanoma were presented at the plenary session of the 2011 annual meeting of the American Society of Clinical Oncology by Paul Chapman, MD, and Jedd Wolchok MD, PhD, members of Memorial Sloan Kettering Cancer Center's Melanoma and Sarcoma service, and lead authors on the studies along with collaborators from more than a one hundred cancer centers worldwide.
Pictured: Craig Thompson
Student Lecture Highlights Major Trends in Modern Cancer Research

More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Study Elucidates How Antibiotics Can Increase Some Harmful Infections in Cancer Patients

An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Sloan Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored

Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.
Bottles filled with liquid
Growing Science: A Decade Devoted to Advancing Cancer Research at the Sloan Kettering Institute

A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Alexander Rudensky
Harmful Immune Reactions Might One Day Be Curbed with Cell-Based Therapy

A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.
Memorial Sloan Kettering Researchers Are 2010 Rock Stars of Science

Three Memorial Sloan Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in <i>GQ</i> magazine's December "Men of the Year" issue.
Hedvig Hricak (left) and David Scheinberg are members of the new Nanotechnology Center's executive committee, which Dr. Scheinberg chairs.
New Nanotechnology Center Combines Cutting-Edge Science with Memorial Sloan Kettering's Expertise in Patient Care

To take advantage of the growing field of nanotechnology, Memorial Sloan Kettering has established a Nanotechnology Center.
Zvi Fuks
Zvi Fuks Elected to the Institute of Medicine

Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.